{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:19:44Z","timestamp":1786123184533,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Opioid dependence is a major public health issue without optimal therapeutics. This study investigates the potential therapeutic effect of dezocine, a nonaddictive opioid, in opioid dependence in rat models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Dezocine was administered intraperitoneally to a morphine-dependent rat model to investigate its effect on withdrawal and conditioned place preference (CPP). Effect of dezocine on morphine withdrawal syndrome and CPP was analyzed using 2-way analysis of variance (ANOVA) followed by Tukey\u2019s post hoc test. Buprenorphine and vehicle solution containing 20% (v\/v) dimethyl sulfoxide were used for positive and negative control, respectively. The astrocytes activation in nucleus accumbens was assessed by immunofluorescence assay of glial fibrillary acidic protein. Effect of dezocine and buprenorphine on the internalization of \u03ba opioid receptor (KOR) was investigated using Neuro2A expressing KOR fused to red fluorescent protein tdTomato (KOR-tdT). Buprenorphine and dezocine were screened against 44 G-protein\u2013coupled receptors, ion channels, and transporter proteins using radioligand-binding assay to compare the molecular targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The mean withdrawal score was reduced in rats treated with 1.25 mg\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      dezocine compared to vehicle-treated control animals starting from the day 1 (mean difference: 7.8; 95% confidence interval [CI], 6.35\u20139.25;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001 by 2-way ANOVA). Significance was observed at all treatment days, including day 7 (mean difference: 2.13; 95% CI, 0.68\u20133.58;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001 by 2-way ANOVA). Furthermore, dezocine inhibited the reinstatement of morphine-induced CPP (mean difference: 314; 95% CI, 197.9\u2013430.1;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001 by 2-way ANOVA) compared to the control group. Chronic morphine administration induced astrocytes activation in nucleus accumbens, which was attenuated by dezocine. Dezocine blocked the agonist-induced KOR internalization in vitro, 1 of the mechanisms involved in the downstream signaling and development of opioid dependence. Dezocine had affinity to norepinephrine and serotonin transporters and sigma-1 receptor, whereas buprenorphine showed no activity against these targets.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Dezocine could potentially be used to alleviate opioid dependence. Due to the unique molecular target profile different from buprenorphine, it might have important value in studying the mechanisms of morphine dependence and developing novel therapeutic approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000003365","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T15:37:36Z","timestamp":1523029056000},"page":"1328-1335","source":"Crossref","is-referenced-by-count":34,"title":["Dezocine Alleviates Morphine-Induced Dependence in Rats"],"prefix":"10.1213","volume":"128","author":[{"given":"Fei-xiang","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China"},{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Babazada","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Ping","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and the National Institute of Mental Health Psychoactive Active Drug Screening Program (NIMH PDSP), School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-hua","family":"Xi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-hua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-feng","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(96)00698-X","article-title":"Effects of the kappa-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat.","volume":"317","author":"Bolanos","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02244761","article-title":"Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release.","volume":"115","author":"Spanagel","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/aps.2010.138","article-title":"The role of kappa-opioid receptor activation in mediating antinociception and addiction.","volume":"31","author":"Wang","year":"2010","journal-title":"Acta Pharmacol Sin"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/emboj\/17.4.886","article-title":"Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal.","volume":"17","author":"Simonin","year":"1998","journal-title":"EMBO J"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cne.903500307","article-title":"Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study.","volume":"350","author":"Mansour","year":"1994","journal-title":"J Comp Neurol"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/105504901750532094","article-title":"Molecular neurobiology of addiction.","volume":"10","author":"Nestler","year":"2001","journal-title":"Am J Addict"},{"key":"R7-20230721","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0306-4522(97)00639-8","article-title":"Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain.","volume":"85","author":"Turchan","year":"1998","journal-title":"Neuroscience"},{"key":"R8-20230721","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0169-328X(99)00021-2","article-title":"Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain.","volume":"66","author":"Wang","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/104454900314672","article-title":"Kappa opioid receptor endocytosis by dynorphin peptides.","volume":"19","author":"Jordan","year":"2000","journal-title":"DNA Cell Biol"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"34631","DOI":"10.1074\/jbc.M304022200","article-title":"Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization.","volume":"278","author":"McLaughlin","year":"2003","journal-title":"J Biol Chem"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0021-5198(19)39723-9","article-title":"The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference.","volume":"58","author":"Suzuki","year":"1992","journal-title":"Jpn J Pharmacol"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-004-2087-0","article-title":"Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors.","volume":"179","author":"Zhang","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"11614","DOI":"10.1523\/JNEUROSCI.3769-07.2007","article-title":"Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.","volume":"27","author":"Bruchas","year":"2007","journal-title":"J Neurosci"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors.","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats.","volume":"316","author":"Carlezon","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00213-008-1122-y","article-title":"Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system.","volume":"200","author":"Redila","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/0269881106060835","article-title":"Naltrexone and buprenorphine combination in the treatment of opioid dependence.","volume":"20","author":"Gerra","year":"2006","journal-title":"J Psychopharmacol"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/ALN.0000000000000076","article-title":"Novel molecular targets of dezocine and their clinical implications.","volume":"120","author":"Liu","year":"2014","journal-title":"Anesthesiology"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1517\/13543784.2012.731393","article-title":"Noradrenergic reuptake inhibition in the treatment of pain.","volume":"21","author":"Hartrick","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0304-3959(90)91157-E","article-title":"The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms.","volume":"42","author":"Sindrup","year":"1990","journal-title":"Pain"},{"key":"R23-20230721","first-page":"685","article-title":"The serotonergic system and its role in cocaine addiction.","volume":"57","author":"Filip","year":"2005","journal-title":"Pharmacol Rep"},{"key":"R24-20230721","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2009.02.084","article-title":"A role for the parafascicular thalamic nucleus in the development of morphine dependence and withdrawal.","volume":"1271","author":"Xiao","year":"2009","journal-title":"Brain Res"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2011.07.063","article-title":"Suppression of acute morphine withdrawal syndrome by adenovirus-mediated \u03b2-endorphin in rats.","volume":"1422","author":"He","year":"2011","journal-title":"Brain Res"},{"key":"R26-20230721","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0028-3908(92)90051-P","article-title":"Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists.","volume":"31","author":"Maldonado","year":"1992","journal-title":"Neuropharmacology"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pbb.2013.11.014","article-title":"Oxytocin via its receptor affects restraint stress-induced methamphetamine CPP reinstatement in mice: involvement of the medial prefrontal cortex and dorsal hippocampus glutamatergic system.","volume":"119","author":"Han","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"R28-20230721","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2008.10.033","article-title":"Cue-elicited drug craving represses ERK activation in mice prefrontal association cortex.","volume":"448","author":"Li","year":"2008","journal-title":"Neurosci Lett"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-013-3204-8","article-title":"Effect of baclofen on morphine-induced conditioned place preference, extinction, and stress-induced reinstatement in chronically stressed mice.","volume":"231","author":"Meng","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-012-2944-1","article-title":"Assessment of the impact of pattern of cocaine dosing schedule during conditioning and reconditioning on magnitude of cocaine CPP, extinction, and reinstatement.","volume":"227","author":"Conrad","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"R31-20230721","first-page":"1516","article-title":"Inhibition of GAP-43 by propentofylline in a rat model of neuropathic pain.","volume":"6","author":"Wu","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"R32-20230721","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.vascn.2013.07.002","article-title":"A G protein-coupled receptor (GPCR) in red: live cell imaging of the kappa opioid receptor-tdTomato fusion protein (KOPR-tdT) in neuronal cells.","volume":"68","author":"Huang","year":"2013","journal-title":"J Pharmacol Toxicol Methods"},{"key":"R33-20230721","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"key":"R34-20230721","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2210-6-3","article-title":"Pharmacological profiles of opioid ligands at kappa opioid receptors.","volume":"6","author":"Gharagozlou","year":"2006","journal-title":"BMC Pharmacol"},{"key":"R35-20230721","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1523\/JNEUROSCI.5973-10.2011","article-title":"Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats.","volume":"31","author":"Muschamp","year":"2011","journal-title":"J Neurosci"},{"key":"R36-20230721","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2008.12.002","article-title":"Alterations of prodynorphin gene expression in the rat mesocorticolimbic system during heroin self-administration.","volume":"1255","author":"Solecki","year":"2009","journal-title":"Brain Res"},{"key":"R37-20230721","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-0102(00)00226-1","article-title":"The involvement of glial cells in the development of morphine tolerance.","volume":"39","author":"Song","year":"2001","journal-title":"Neurosci Res"},{"key":"R38-20230721","doi-asserted-by":"crossref","first-page":"43137","DOI":"10.1038\/srep43137","article-title":"Dezocine exhibits antihypersensitivity activities in neuropathy through spinal \u03bc-opioid receptor activation and norepinephrine reuptake inhibition.","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"R39-20230721","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2013.01.068","article-title":"Sigma 1 receptor: a new therapeutic target for pain.","volume":"716","author":"Zamanillo","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"R40-20230721","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/jpet.105.084525","article-title":"Cocaine up-regulates Fra-2 and sigma-1 receptor gene and protein expression in brain regions involved in addiction and reward.","volume":"314","author":"Liu","year":"2005","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201906000-00046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:19:19Z","timestamp":1786112359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201906000-00046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000003365","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}